Discover

BLLN
BillionToOne, Inc.
97.82
2 x 97.82
1 x 98.34
bid
ask
-
0.83
0.84%
12:36 PM
timesize
Ytd19.53%
1y-10.21%
94.45
day range
99.07
61.96
52 week range
150.44
Open97.64Prev Close98.65Low94.45High99.07Mkt Cap4.51B
Vol233.91KAvg Vol787.24KEPS0.70P/E140.09Forward P/E70.22
BetaN/AShort Ratio3.19Inst. Own35.62%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-0550-d Avg115.95200-d Avg95.401yr Est121.43

BLLN News

Billiontoone, Inc. (NASDAQ:BLLN) Receives $126.71 Average PT from Brokerages
defenseworld.net
Billiontoone, Inc. (NASDAQ:BLLN) Receives $126.71 Average PT from Brokerages

Billiontoone, Inc. (NASDAQ: BLLN - Get Free Report) has been given a consensus rating of "Moderate B

BillionToOne: A Softer Quarter After Heightened Expectations
seekingalpha.com
BillionToOne: A Softer Quarter After Heightened Expectations

BillionToOne experienced a sharp post-earnings sell-off despite maintaining full-year guidance and s

12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Intraday Session

Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 107.8% to $1.39 during Thursday'

12 Health Care Stocks Moving In Thursday's Pre-Market Session
benzinga.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session

Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 86.9% to $1.25 during Thursday's

BillionToOne (BLLN) Reports Q2 Earnings: What Key Metrics Have to Say
zacks.com
BillionToOne (BLLN) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for BillionToOne (BLLN) give a sense of how the business perf

Billiontoone Q2 Earnings Call Highlights
marketbeat.com
Billiontoone Q2 Earnings Call Highlights

Billiontoone NASDAQ: BLLN reported second-quarter 2026 revenue growth of 64% year over year, driven

12 Health Care Stocks Moving In Wednesday's After-Market Session
benzinga.com
12 Health Care Stocks Moving In Wednesday's After-Market Session

Gainers Creative Medical Tech (NASDAQ:CELZ) stock moved upwards by 31.4% to $0.88 during Wednesday&

BillionToOne Reports Second Quarter 2026 Results and Reiterates 2026 Revenue Guidance
globenewswire.com
BillionToOne Reports Second Quarter 2026 Results and Reiterates 2026 Revenue Guidance

MENLO PARK, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-gene

BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar
prnewswire.com
BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Stra

Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the natio

BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026
globenewswire.com
BillionToOne to Report Second Quarter 2026 Financial Results on August 5, 2026

MENLO PARK, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-gene

A BillionToOne Insider Sold 801 Shares as Revenue Jumped 84%
fool.com
A BillionToOne Insider Sold 801 Shares as Revenue Jumped 84%

According to a Form 4 filing, a BillionToOne executive sold 801 shares of Class A Common Stock at $1

Tom Gardner's Five Stocks for the Long Term: Big Diversification, AI Research, and Caution
fool.com
Tom Gardner's Five Stocks for the Long Term: Big Diversification, AI Research, and Caution

Tom Gardner makes the case for fifty-stock portfolios and AI-powered research, then names five compa

Are Medical Stocks Lagging BillionToOne, Inc. (BLLN) This Year?
zacks.com
Are Medical Stocks Lagging BillionToOne, Inc. (BLLN) This Year?

Here is how BillionToOne (BLLN) and Concentra Group (CON) have performed compared to their sector so

BillionToOne's Northstar Response® Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-of-Care Imaging for Cancer Patients in Peer-Reviewed Study
gurufocus.com
BillionToOne's Northstar Response® Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-o

BillionToOne's Northstar Response Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-o

BillionToOne's Northstar Response® Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-of-Care Imaging for Cancer Patients in Peer-Reviewed Study
prnewswire.com
BillionToOne's Northstar Response® Is a Stronger Predictor of Immunotherapy Outcomes Than Standard-o

Tissue-free ctDNA monitoring was the dominant independent predictor of survival across 12 tumor type

Is BillionToOne, Inc. (BLLN) Stock Outpacing Its Medical Peers This Year?
zacks.com
Is BillionToOne, Inc. (BLLN) Stock Outpacing Its Medical Peers This Year?

Here is how BillionToOne (BLLN) and Eledon Pharmaceuticals, Inc. (ELDN) have performed compared to t

BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference
globenewswire.com
BillionToOne to Participate in the William Blair 46th Annual Growth Stock Conference

MENLO PARK, Calif., May 27, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-gener

Baron Health Care Fund Q1 2026 Portfolio Activity
seekingalpha.com
Baron Health Care Fund Q1 2026 Portfolio Activity

During the quarter, we added 9 new positions and exited 11 positions, bringing the number of positio

Does BillionToOne (BLLN) Have the Potential to Rally 37% as Wall Street Analysts Expect?
zacks.com
Does BillionToOne (BLLN) Have the Potential to Rally 37% as Wall Street Analysts Expect?

The average of price targets set by Wall Street analysts indicates a potential upside of 37% in Bill

Wall Street Analysts Predict a 25.63% Upside in BillionToOne (BLLN): Here's What You Should Know
zacks.com
Wall Street Analysts Predict a 25.63% Upside in BillionToOne (BLLN): Here's What You Should Know

The mean of analysts' price targets for BillionToOne (BLLN) points to a 25.6% upside in the stock. W

BillionToOne (BLLN) Reports Q1 Earnings: What Key Metrics Have to Say
zacks.com
BillionToOne (BLLN) Reports Q1 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for BillionToOne (BLLN) give a sense of how its business performed in t

Earnings Scheduled For May 6, 2026
benzinga.com
Earnings Scheduled For May 6, 2026

BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance
globenewswire.com
BillionToOne Reports First Quarter 2026 Results and Raises 2026 Revenue Guidance

MENLO PARK, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-gener

BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screening and invasive diagnostics
prnewswire.com
BillionToOne Launches Unity Confirm™: A category-defining test that bridges the gap between screenin

A breakthrough in prenatal care, Unity Confirm enables non-invasive confirmation for high-risk scree

Joby Aviation Is 'Too Risky,' But This Industrial Stock Is A 'Winner': Jim Cramer
benzinga.com
Joby Aviation Is 'Too Risky,' But This Industrial Stock Is A 'Winner': Jim Cramer

Cramer shared his thoughts on various stocks, calling Joby Aviation too risky, BillionToOne a winner

Marriott Vacations To Rally Around 52%? Here Are 10 Top Analyst Forecasts For Thursday
benzinga.com
Marriott Vacations To Rally Around 52%? Here Are 10 Top Analyst Forecasts For Thursday

Summary:Top Wall Street analysts changed outlook on top names. Analyst ratings page shows all chang

Earnings Scheduled For March 4, 2026
benzinga.com
Earnings Scheduled For March 4, 2026

Earnings Scheduled For December 9, 2025
benzinga.com
Earnings Scheduled For December 9, 2025

This Joby Aviation Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday
benzinga.com
This Joby Aviation Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Monday